Partner with VCs, biopharma leaders and emerging academic innovatorsPartnering opens Aug. 26

You will meet a “who’s who” of the biopharma industry, including executives, investors and innovators from:

  • Abingworth
  • Allen Institute
  • Alnylam Pharmaceuticals
  • Apollo Health Ventures
  • AstraZeneca
  • Babraham
  • Bayer
  • Blackstone
  • BIA
  • BioGeneration Ventures
  • BioMarin Pharmaceutical
  • British Business Bank
  • Cambridge Academy of Therapeutic Sciences
  • Cambridge Enterprise
  • Cambridge Innovation Capital
  • Cambridge Stem Cell
  • Cambridge University
  • Cancer Research UK
  • Daiichi Sankyo
  • Edinburgh Innovations
  • Eisai
  • Eli Lilly
  • Evotec
  • Flagship Pioneering
  • F-Prime Capital
  • Forbion
  • Francis Crick Institute
  • Ghent University
  • GV
  • GSK
  • Harvard University
  • HSBC
  • Immunocore
  • J&J Innovation
  • Kyowa Kirin
  • Kurma Partners
  • Life Arc Ventures
  • Lundbeckfonden Capital
  • Medicxi
  • Milner
  • Monograph Capital
  • Novartis
  • Novo Holdings
  • Novo Nordisk
  • Oxford Science Enterprises
  • Oxford University
  • Panakes Partners
  • PJT Partners
  • Profound Therapeutics
  • Roche
  • Rosetta Capital
  • Royalty Pharma
  • Sanger Institute
  • Seroba
  • Sofinnova Partners
  • Softbank Investment Advisors
  • SR One
  • SV Health Investors
  • Syncona Investment
  • UK Biobank
  • University of Cambridge
  • University of Glasgow
  • Versant Ventures
  • VIB
  • Welcome Genome Campus
  • And many more...